Cook Research Incorporated

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Cook Research Incorporated sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).

24 total trials 4 currently recruiting 20 completed top decile by trial count

Cook Research Incorporated: 24 sponsored US clinical trials, 4 recruiting.

Cook Research Incorporated sponsors 24 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 20 completed. The most-studied condition in this pipeline is Cardiac Electrophysiology, with 1 trials.

Top-decile sponsor footprint

Cook Research Incorporated ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

20 of 20 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

24 total, page 1 of 1

RECRUITING NA

EVERO Drug-coated Balloon (DCB) Randomized Trial

NCT07144150

RECRUITING

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

NCT05881798

RECRUITING

Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

NCT06986954

RECRUITING NA

Zenith® Fenestrated+ Clinical Study

NCT04875429

COMPLETED

EchoTip AcuCore Post-Market Clinical Study

NCT06358001

COMPLETED

Biodesign® Otologic Repair Graft

NCT04635228

COMPLETED

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

NCT04668664

COMPLETED

Post-market Assessment of Biodesign Dural Repair Grafts

NCT04057157

COMPLETED

Flourish™ Pediatric Esophageal Atresia

NCT03615495

COMPLETED

Transvenous Lead Removal Post-Market Clinical Study

NCT03688412

COMPLETED NA

Cook Enforcer Post-Market Study

NCT03552289

COMPLETED NA

Zenith® p-Branch® Endovascular Graft Pivotal Study

NCT02396199

COMPLETED NA

Zenith® Low Profile AAA Endovascular Graft

NCT02535065

COMPLETED NA

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

NCT02571907

COMPLETED NA

Fenestrated AAA Endovascular Graft Post-Approval Study

NCT01990950

COMPLETED NA

Cook IVC Filter Study

NCT02046096

COMPLETED NA

VIVO Clinical Study

NCT01970007

COMPLETED NA

Zilver® PTX® V Clinical Study

NCT01901289

COMPLETED NA

TRANSFIX Zenith® Transection Clinical Study

NCT01688050

COMPLETED NA

Zenith® p-Branch® OTS Multicenter Study

NCT01740700

COMPLETED NA

Zenith® Dissection Clinical Trial

NCT01568320

COMPLETED NA

TX2® Low Profile TAA Endovascular Graft

NCT01151020

COMPLETED NA

Zenith TX2® Post-market Approval Study

NCT00813358

COMPLETED NA

Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study

NCT01652235

What is open in the Cook Research Incorporated pipeline

4 recruiting of 24 indexed (17% open); 20 completed (83%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cardiac Electrophysiology (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Cook Research Incorporated: open-pipeline peers nationwide

Peers matched on 24 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Cook Research Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30% Total trials Recruiting share Cook Research IncorporatedAcrotech BiopharmaAgenusAkebia TherapeuticsBlueprint Medicines CorporationAdageneAgendiaAkamis BioAngiodynamics
Cook Research Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cook Research Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 24 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Cook Research Incorporated page

24 registered trials is a research-attention snapshot, not an endorsement of Cook Research Incorporated or any single study.

  • 4 of Cook Research Incorporated's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cardiac Electrophysiology is the condition Cook Research Incorporated studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiac Electrophysiology trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cook Research Incorporated pipeline card: 24 registered trials from official public datasets.Report a data error.